Dis-Chem PharmaciesJSE:DCP -0.86%85 EBITDA Margin % is 3.57% as of Feb. 2026, which is 54% below its 10-year median of 7.81. GuruFocus rates JSE:DCP with a GF Score™ of 85/100 and a GF Value™ of R38.13 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Dis-Chem Pharmacies ranks worse than 65.51% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Dis-Chem Pharmacies EBITDA Margin % Related Terms
Dis-Chem Pharmacies EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Dis-Chem Pharmacies's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dis-Chem Pharmacies EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Dis-Chem Pharmacies's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dis-Chem Pharmacies (JSE:DCP) has a EBITDA Margin % of 3.57% as of Feb. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Dis-Chem Pharmacies and its competitors. This is 54% below median its historical median of 7.81. Over the past decade, Dis-Chem Pharmacies' EBITDA Margin % has ranged from 4.55 to 8.81. According to the industry distribution chart, Dis-Chem Pharmacies ranks #435 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 65.5%.
Is Dis-Chem Pharmacies' EBITDA Margin % too high?
Dis-Chem Pharmacies' current EBITDA Margin % of 3.57% is 54% below median its 10-year median of 7.81. Over the past 10 years, this metric has ranged from a low of 4.55 to a high of 8.81. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Dis-Chem Pharmacies' value of 3.57% is 65% below this industry median. Based on the distribution chart, Dis-Chem Pharmacies ranks #435 out of 664 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Dis-Chem Pharmacies has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' EBITDA Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Dis-Chem Pharmacies ranks #435 out of 664 companies for EBITDA Margin %. This places Dis-Chem Pharmacies in the lower half of its industry. The industry median EBITDA Margin % is 10.21. Dis-Chem Pharmacies' value of 3.57% is 65% below this benchmark. Historically, Dis-Chem Pharmacies' own EBITDA Margin % has ranged from 4.55 to 8.81 over the past decade. While the company's 10-year median is 7.81 vs. the industry median of 10.21, Dis-Chem Pharmacies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dis-Chem Pharmacies's current EBITDA Margin % of 3.57% is 65% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Dis-Chem Pharmacies and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dis-Chem Pharmacies's current EBITDA Margin % is 3.57%, which is 54% below median its own 10-year median of 7.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.13, compared to a current price of R32.22 — trading 15.5% below its estimated fair value. The current EBITDA Margin % is 3.57%, which is 54% below median its 10-year median of 7.81 and 65% below the Healthcare Providers & Services industry median of 10.21. Dis-Chem Pharmacies' overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current EBITDA Margin % is 3.57% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?
Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued.
The current stock price of R32.22 is trading 15.5% below its estimated GF Value™ of R38.13.
GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.
Key valuation signals for JSE:DCP:
EBITDA Margin %: 3.57% (54% below median its 10-year median of 7.81)
GF Value™: R38.13 vs. price of R32.22 (15.5% below fair value)
Industry Position: 65% below the Healthcare Providers & Services median (#435 of 664)
No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
85GF Score
Get the complete analysis for JSE:DCP
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:DCP has been successfully added to your 
